Objective: To compare characteristics and outcomes of benign prostatic hyperplasia patients undergoing prostate laser ablation with those undergoing laser enucleation using a nationwide cohort. Methods: Men who underwent prostate laser ablation (n = 10 054) or laser enucleation (n = 1705) between 2011 and 2015 were identified by the common procedural terminology code as recorded in the National Surgical Quality Improvement Program database. Preoperative, intraoperative and postoperative parameters were compared between the groups using univariate and multivariate analysis. Results: Prostate laser ablation patients were older, had more comorbidities and were more likely to have abnormal laboratory values. Enucleations were significantly longer and more likely to result in a hospital stay >1 day. Enucleation patients were also more likely to require a blood transfusion postoperatively, but less likely to experience urinary tract infection and sepsis on both univariate and multivariate analysis adjusted for preoperative and intraoperative factors. Conclusions: Although laser enucleation and prostate laser ablation are both considered minimally invasive techniques, significant differences in patient selection, intraoperative factors and postoperative complications are identified in this national cohort. The present study shows that despite similar outcomes in prospective singlecenter studies, prostate laser ablation and laser enucleation have distinct practice patterns in a broader national context.
Introduction
Ablation and enucleation are surgical laser techniques utilized for bladder outlet obstruction as a result of BPH. LEP results in shelling of individual lobes of prostatic adenoma along the surgical capsule in a fashion similar to simple prostatectomy. LAP is achieved by vaporization of the adenoma, working from the surface mucosa toward the surgical capsule. Both ablation and enucleation are considered minimally invasive techniques with superior safety profiles compared with the reference gold standard of TURP. [1] [2] [3] [4] Several studies have compared LEP and LAP head-to-head. [5] [6] [7] [8] [9] [10] While providing invaluable insight on functional outcomes, these studies are usually limited to a single high-volume surgeon or center and might not reflect "real-world" experience with laser prostate surgery. In fact, there is a paucity of literature examining practice patterns of laser prostate surgery across a wide range of settings and surgeons. In such a broader setting, differences between LAP and LEP might arise because of distinct learning curves, surgical techniques and equipment availability -factors that would not be apparent in the hands of an expert surgeon operating at a single center. 11 The objective of the present study was to examine how perioperative factors and postoperative outcomes differ for LEP and LAP across a large national cohort that includes a wide range of practice settings and varying degrees of surgeon experience. We sought to determine if a diverse national cohort can reflect differences between ablation and enucleation, such as a steeper learning curve, that are not accounted for in single-surgeon or single-center cohorts.
Methods Data
Data from the NSQIP participant-use file were used for the present study. The general methods of the NSQIP have been described previously in detail. 12 In brief, the NSQIP collects clinical data on patients undergoing surgical procedures at >200 hospitals encompassing variables that include preoperative demographic and comorbidity data, and intraoperative and perioperative complications for 30 days after the operation. The accuracy of the data is ensured through rigorous quality control measures, including intensive training for data collectors, and by carrying out interrater reliability audits of participating sites.
Study population
Patients were included in the study if they had undergone LAP or LEP as the primary procedure between 1 January 2011 and 31 December 2015. Patients who underwent LAP and LEP were identified by Common Procedural Terminology codes corresponding to 52 648 and 52 649, respectively. Multiple imputations (n = 20) were used to account for missing data, which included 6806 missing records for preoperative INR, 3609 missing records for pre-existing bleeding disorder and 1734 missing records for preoperative hematocrit.
Preoperative parameters
Preoperative medical parameters included race, age, American Society of Anesthesiologists class, BMI, diabetes, smoking, dyspnea on exertion, severe chronic obstructive pulmonary disease, end-stage renal disease, congestive heart failure, bleeding disorder, history of prior cardiac surgery, stroke with neurological deficit, and preoperative steroid and antihypertensive medication use. Preoperative laboratory values were serum leukocytes, platelets, creatinine and albumin concentration, hematocrit, and INR.
Perioperative parameters
Perioperative parameters included admission type (outpatient vs inpatient), operative time, type of anesthesia, number of intraoperative blood transfusions and length of hospital stay.
Postoperative occurrences
The 30-day postoperative outcomes included postoperative transfusion, UTI, sepsis, readmission and reoperation. Postoperative UTI was defined by one of two criteria: one symptom and a positive urine culture (>10 5 colonies/mL urine) or two symptoms and a urine laboratory value suggestive of a UTI. Sepsis was defined in accordance with the Systemic Inflammatory Response Syndrome criteria, and included occurrences from mild physiological abnormalities to septic shock.
Statistical analysis
The values of categorical variables are presented as percentages in each category. Mean with standard deviation and median with interquartile range were calculated for normally and non-normally distributed continuous variables, respectively. Pearson's v 2 -test was used to assess differences in categorical parameters between LEP and LAP, whereas Student's t-test or Wilcoxon rank-sum test were used to examine differences in normally and non-normally distributed continuous variables, respectively. Associations between the procedure carried out and postoperative events were examined individually using multivariate logistic regression models adjusted for all preoperative and intraoperative factors. Odds ratios and 95% confidence were reported. Statistical significance was defined as a two-tailed P < 0.05. All calculations were carried out using Stata/SE version 12.0 (StataCorp, College Station, TX, USA).
Results
A total of 11 759 men underwent laser prostate surgery between 2011 and 2015. Of these, 10 054 (85.5%) underwent LAP and 1705 (14.5%) underwent LEP. Selected demographic and medical characteristics of both groups are shown in Table 1 . Overall, men who underwent LEP were younger and healthier than men who underwent LAP. In contrast, LEP participants had a slightly higher mean BMI. On multivariate analysis adjusted for all medical and demographic characteristics, age, American Society of Anesthesiologists class, BMI and incidence of bleeding disorder remained statistically different between LEP and LAP. Preoperative laboratory values for both procedures are shown in Table 2 . LAP patients were more likely to have laboratory values that would predispose to postoperative bleeding; that is, they had a higher INR, lower serum hematocrit and lower platelet concentration.
Operative characteristics are shown in Table 3 . Operative time was longer for LEP, and LEP was less likely to be carried out in the outpatient setting. Participants who underwent LEP were more likely to have a hospital stay >1 day. No intraoperative transfusions were administered after either procedure. The 20-day postoperative events are summarized in Table 4 . LAP patients were more likely to develop postoperative UTI and sepsis, but LEP patients were more likely to require a postoperative transfusion. Readmission occurred more frequently after LAP, whereas rates of reoperation were similar. The most common reasons for readmission were gross hematuria (0.77%), UTI (0.66%), sepsis (0.45%), urinary retention (0.27%) and electrolyte abnormality (0.10%).
The results of multivariate analysis are shown in Table 5 . After adjusting for all preoperative and intraoperative parameters, LEP was associated with a higher likelihood of transfusion and a lower likelihood of UTI (OR 0.46, 95% CI 0.14-0.93) and sepsis (OR 0.36, 95% CI 0.14-0.93). Likelihood of readmission was not different between the procedures.
Discussion
Multiple laser systems have been introduced and investigated for bladder outlet obstruction secondary to BPH, but they follow one of two surgical approaches to prostate reduction: ablation or enucleation. 13 Comparisons of laser techniques with TURP have shown favorable outcomes, and demonstrated that laser surgery can be used in patients who normally would not be candidates for TURP. 4 Several studies have also compared LAP with LEP, and at least two compared the techniques in a randomized controlled fashion. 5, 6 While providing high-quality evidence, these reports rely on the experience of a single high-volume surgeon or surgical center. In contrast, our goal was to provide insight to how laser ablation and enucleation are utilized by a broad spectrum of urologists in the USA.
Whereas a single-center study by a master surgeon shows what is possible to achieve, it is difficult to apply those outcomes to the general urologist or a urologist at the beginning of their career in laser prostate surgery. A question, such as "how long should a LEP take me?", is challenging to answer, as even among high-volume surgeons there is significant variation. For example, although the average total surgical time for LEP was 107 min and 90 min in the studies by Elmansi et al. and Elterman et al., it was just 60 min in the cohort reported by Misrai et al. 5, 6, 9 Although different lasers were used for enucleation in these studies, the discrepancy in surgical time likely reflects variations in surgical technique in addition to differences in equipment. By examining thousands of patients treated by hundreds of surgeons, the present study is closer to showing how laser prostate surgery is practiced by the average urologist and eliminates some of the deviation from the mean of single-surgeon cohorts. Thus, we hope that this report provides a frame of reference to the self-inspecting clinician or to the clinician using laser prostate surgery for the first time.
Despite significant differences between LEP and LAP with respect to learning curve, technical difficulty and approach to tissue reduction, there is a paucity of literature examining whether these differences are associated with a bias in patient selection. We showed that LEP is carried out in a significantly younger and healthier patient population than LAP. Patients who undergo enucleation are less likely to have medical comorbidities and to have abnormal laboratory analysis. This difference in patient characteristics might be explained by the technique variability allowed by LAP. By ablating the adenoma from the urethral lumen to the prostatic capsule, the surgeon can halt a procedure after removing a small amount of tissue and still improve LUTS. In contrast, enucleation depends on removing entire lobes of adenomaif the procedure is stopped before a lobe is removed, it is unlikely to result in clinical improvement. Thus, a frail patient might be preferentially selected to undergo a procedure with an easily adjustable duration that can lead to symptom improvement even with a small amount of tissue removed. Overall, the present findings suggest that LAP and LEP are utilized in distinct populations, and that LAP is practiced differently than shown in single-surgeon reports, which aim for maximal tissue reduction. Markedly more frequent utilization of spinal anesthesia, commonly administered to patients who cannot tolerate endotracheal anesthesia due to comorbidities, relatively short operative time and length of hospital stay all suggest that LAP is rarely used to remove adenoma all the way to the capsule, but rather to minimize morbidity in frail patients. We also identified significant differences between ablation and enucleation with respect to 30-day postoperative outcomes. Although both procedures were associated with a low postoperative transfusion rate, LEP patients were almost threefold as likely to require a transfusion, and were more likely to return to the operating room for bleeding, despite having a higher preoperative hematocrit, and lower likelihood of having a bleeding disorder or an abnormal INR. Differences in surgical technique and laser properties could account for this difference. The holmium laser, commonly utilized for enucleation, is pulsed and operates at a lower power (80-100 W) than the continuous GreenLight laser (180 W) usually used for ablation. These properties of the ablation laser result in superior coagulation. Additionally, vaporization begins at the urethral lumen and the prostatic capsule might not be reached during a LAP, but the enucleating surgeon approaches adenoma by immediately developing a surgical plane at the prostatic capsule. Inadvertent entry into the venous sinuses adjacent to the capsule might contribute to the increased risk of bleeding complications. Although postoperative transfusion requirement is not commonly reported in BPH surgery literature, the study by Elmansi et al. also suggests that enucleation could be associated with an increased likelihood of hematuria and clot evacuation. 5 We also found that ablation was associated with a higher risk of infectious complications in univariate and multivariate analysis adjusted for age and comorbidities. Postoperative retention might be a factor that could account for this finding, but we did not identify any statistically significant differences in postoperative admissions for urinary retention (P = 0.277) or in the likelihood of returning to the operating room for additional tissue resection (P = 0.224). In the report by Misrai et al., patients who underwent ablation also had a higher rate of UTI, although the number of patients was too small to show a significant difference. 6 One potential theory is that disruption of the adenoma during ablation might contribute to the increased risk of infection. If intraprostatic bacteria is present, vaporization of the host tissue can lead to bacterial release into the urinary tract or the blood stream.
14 In contrast, enucleation removes prostatic lobes in toto, and the risk of unroofing bacterial colonies during tissue removal is decreased. Another possible explanation is that LAP patients, being frailer and older, were more likely to be catheter- Red blood cell transfusions, n (%) 0 (0.0) 0 (0.0) 1.000 dependent preoperatively, raising the risk of bacteriuria and postoperative infectious complications. Limitations of NSQIP data preclude identification of other factors that might be responsible for the differences in bleeding and infectious complications between prostate ablation and enucleation. For example, we cannot account for postoperative catheterization time, total energy used, amount of prostate tissue removed or the particular laser used in any given procedure. As holmium, thulium, diode and potassium titanyl phosphate lasers have all been used to ablate, and even enucleate, differences in bleeding or infectious outcomes should not be assumed to be secondary to a particular energy source. In addition, while NSQIP carefully tracks general 30-day outcomes, outcomes relevant to lower urinary tract function are not recorded. Finally, we cannot account for certain biases that might have affected the present findings. For example, enucleations are more likely to be referral cases and to be carried out on larger glands. As NSQIP does not provide information on prostate size or practice setting, the present study cannot address these variables and their effect on patient selection or surgical outcome. We attempted to account for prostate size by using operative time as a surrogate, and although differences between LEP and LAP persisted in analyses adjusted for this variable, operative time is far from being a perfect representative for prostate size.
Despite its limitations, we hope that the present study sheds light on differences between ablation and enucleation from a multicenter multisurgeon perspective. Whereas singlecenter studies show how laser prostate surgery should be practiced, a large multicenter cohort can reflect how laser prostate surgery is practiced in actuality. While we are not aware of any studies that examined differences between laser ablation and enucleation using a national cohort, several previous reports have utilized NSQIP to compare laser prostate surgery and TURP. [15] [16] [17] In addition to describing differences in practice patterns of laser prostate surgery, our goal was to add to the armamentarium of the general urologist providing preoperative counseling to the BPH patient. We hope that the clinician utilizing either, or both, of these techniques will find our report useful for providing patients with complication and outcome rates derived from a multicenter cohort. Although an established BPH surgeon will likely have their own data in this respect, generalized outcome information might be particularly useful to the young urologist, or a urologist newly adopting laser prostate surgery.
In summary, we report on the practice patterns of laser prostate surgery using a large cohort of patients and surgeons. We found that the number of ablations carried out between 2011 and 2015 far outnumbered the number of enucleations. To our surprise, we found that enucleation patients were younger and healthier than their ablation counterparts, despite both procedures having a superior safety profile to monopolar TURP. We also identified discrepancies between LAP and LEP outcomes, with bleeding complications, although rare overall, being more common after enucleation; and infectious complications being more common after ablation. While data limitations prevented us from identifying the underlying reasons for these differences, we believe that these distinct surgical approaches to the adenoma present different risks and can explain the present findings.
